Sex differences in atrial fibrillation ablation outcomes in patients with heart failure
Journal of Interventional Cardiac Electrophysiology · 2024
DOI: 10.1007/s10840-024-01833-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, 2024. Verfasst von Siddharth Agarwal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Catheter Ablation, Hospital Mortality. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: There is a lack of data on the impact of sex on the outcomes of patients with heart failure (HF) undergoing atrial fibrillation (AF) ablation. We aimed to analyze the association of sex with outcomes of atrial fibrillation ablation in patients with heart failure. METHODS: The National Readmissions Database (NRD) was analyzed from 2016 to 2019 to identify patients ≥ 18 years old with heart failure (HF) undergoing AF ablation. The outcomes of interest included peri-procedural complications, in-hospital mortality, resource utilization, and unplanned 1-year readmissions. The final cohort was divided into patients with HFrEF and HFpEF and outcomes were compared between males and females in both cohorts. RESULTS: A total of 23,277 patients with HF underwent AF ablation between 2016 and 2019, of which 14,480 had HFrEF and 8,797 had HFpEF. Among patients with HFrEF, 61.6% were males and 38.4% were females whereas, among patients with HFpEF, 35.4% were males and 64.6% were females. On a multivariable-adjusted analysis, in patients with HFrEF, there was no difference in the odds of in-hospital mortality, peri-procedural complications, or 1-year HF-related/AF-related/all-cause readmissions between males and females. In patients with HFpEF, females had a higher risk 1-year HF-related readmissions (adjusted hazards ratio: 1.46; 95% CI: 1.13-1.87; p = 0.01), without any difference in the 1-year AF-related/all-cause readmissions, in-hospital mortality, or peri-procedural complications. CONCLUSION: Our results show that females with HFrEF undergoing AF ablation have similar outcomes whereas females with HFpEF have higher 1-year HF readmissions with no difference in the other outcomes, compared to males.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Department of Internal Medicine, Yale School of Medicine, Waterbury, CT, USA.
- Department of Cardiology, Mayo Clinic, Rochester, MN, USA.
- Division of Cardiovascular Medicine, University of California Davis, Sacramento, CA, USA.
- Department of Cardiology, University of Oklahoma Health Sciences Center, 800 Stanton L Young Blvd, Suite 5400, Oklahoma City, OK, 73104, USA.
- Department of Cardiology, University of Oklahoma Health Sciences Center, 800 Stanton L Young Blvd, Suite 5400, Oklahoma City, OK, 73104, USA. Stavros-stavrakis@ouhsc.edu.
Zitieren
APA
Agarwal, S., Farhat, K., Khan, M. S., DeSimone, C. V., Deshmukh, A., Munir, M. B., Asad, Z. U. A., & Stavrakis, S. (2024). Sex differences in atrial fibrillation ablation outcomes in patients with heart failure. Journal of Interventional Cardiac Electrophysiology. https://doi.org/10.1007/s10840-024-01833-8
Vancouver
Agarwal S, Farhat K, Khan MS, DeSimone CV, Deshmukh A, Munir MB, et al. Sex differences in atrial fibrillation ablation outcomes in patients with heart failure. Journal of Interventional Cardiac Electrophysiology. 2024. doi:10.1007/s10840-024-01833-8
BibTeX
@article{Agarwal2024,
author = {Agarwal, Siddharth and Farhat, Kassem and Khan, Muhammad Salman and DeSimone, Christopher V and Deshmukh, Abhishek and Munir, Muhammad Bilal and Asad, Zain Ul Abideen and Stavrakis, Stavros},
title = {Sex differences in atrial fibrillation ablation outcomes in patients with heart failure},
journal = {Journal of Interventional Cardiac Electrophysiology},
year = {2024},
doi = {10.1007/s10840-024-01833-8}
}
EUVIMED